Clinical Trial Update: Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism [Phase 4]

View source ↗

Summary

Post-marketing Phase 4 trial update for Monteplase (Cleactor) in patients with acute pulmonary embolism completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Monteplase (Monteplase)

Snippet

Sponsor: Eisai Inc. | Conditions: Pulmonary Embolism | Phase 4 | Status: COMPLETED